SCHEMBL4094288

SCHEMBL4094288

Cc1nc(-c2ccc(Cl)c(N)c2)cs1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 3/20 0.58
TSHR P16473 1/20 0.58
GAA P10253 4/20 0.55
ALDH1A1 P00352 3/20 0.55
MAPT P10636 3/20 0.55
KDM4E B2RXH2 2/20 0.55
POLB P06746 2/20 0.55
HPGD P15428 1/20 0.55
ESR2 Q92731 1/20 0.55
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HSD17B10 Q99714 1/20 0.50
ROCK2 O75116 1/20 0.49
PIM1 P11309 1/20 0.49
GSK3B P49841 1/20 0.49
AURKB Q96GD4 1/20 0.49
GFER P55789 1/20 0.49
HTT P42858 1/20 0.45
TRIM24 O15164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1765095 0.85 MAPT (0.60) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL3346281 0.83 RECQL (0.61) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL12021849 0.81 RECQL (0.58) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL19627004 0.81 ABL1 (0.59) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL8083706 0.78 MAPT (0.69) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL19626486 0.77 ABL1 (0.59) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL14259198 0.77 GAA (0.73) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL19627015 0.77 RECQL (0.51) RECQLTSHRGAAALDH1A1MAPT
SCHEMBL4458525 0.76 KDM4E (0.58) RECQLGAAALDH1A1MAPTKDM4E
SCHEMBL2405184 0.75 RAB9A (0.71) RECQLGAAALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 RECQL 2220/4885TSHR 4599/4885GAA 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.